Gossypin
(Synonyms: 棉纤维素) 目录号 : GC60180A flavonoid glycoside with diverse biological activities
Cas No.:652-78-8
Sample solution is provided at 25 µL, 10mM.
Gossypin is a flavonoid glycoside originally isolated from H. vitifolius that has diverse biological activities.1,2,3,4,5 It inhibits RANKL-induced osteoclastogenesis in RAW 264.7 cells when used at a concentration of 5 ?M.1 Gossypin inhibits Aurora B kinase (IC50 = 11.07 ?M in a cell-free assay using the human enzyme), as well as Aurora A kinase and p90 ribosomal S6 kinase 2 (RSK2) at 20 ?M.2,3 It induces cell cycle arrest at the G2/M phase and apoptosis in HGC-27 gastric cancer cells.3 Gossypin decreases lactate dehydrogenase (LDH) release induced by the glutathione-depleting agent D,L-buthionine (S,R)-sulfoximine in primary rat cortical cells (IC50 = 7.4 ?g/ml).4 It reduces acetic acid-induced writhing in mice, an effect that can be reversed by the opioid antagonist naloxone, in a dose-dependent manner.5
1.Kunnumakkara, A.B., Nair, A.S., Ahn, K.S., et al.Gossypin, a pentahydroxy glucosyl flavone, inhibits the transforming growth factor beta-activated kinase-1-mediated NF-κB activation pathway, leading to potentiation of apoptosis, suppression of invasion, and abrogation of osteoclastogenesisBlood109(12)5112-5121(2007) 2.Jung, Y., Shin, S.Y., Yong, Y., et al.Plant-derived flavones as inhibitors of aurora B kinase and their quantitative structure-activity relationshipsChem. Biol. Drug Des.85(5)574-585(2015) 3.Wang, L., Wang, X., Chen, H., et al.Gossypin inhibits gastric cancer growth by direct targeting of AURKA and RSK2Phytother. Res.33(3)640-650(2019) 4.Yoon, I., Lee, K.H., and Cho, J.Gossypin protects primary cultured rat cortical cells from oxidative stress- and beta-amyloid-induced toxicityArch. Pharm. Res.27(4)454-459(2004) 5.Viswanathan, S., Sambantham, P.T., Reddy, K., et al.Gossypin-induced analgesia in miceEur. J. Pharmacol.98(2)289-291(1984)
Cas No. | 652-78-8 | SDF | |
别名 | 棉纤维素 | ||
Canonical SMILES | O=C1C(O)=C(C2=CC=C(O)C(O)=C2)OC3=C(O[C@H]4[C@@H]([C@H]([C@@H]([C@@H](CO)O4)O)O)O)C(O)=CC(O)=C13 | ||
分子式 | C21H20O13 | 分子量 | 480.38 |
溶解度 | 30 mg/ml in DMF,PBS (pH 7.2) (1:2): 0.3 mg/ml in DMF,25 mg/ml in DMSO | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
![]() |
1 mg | 5 mg | 10 mg |
1 mM | 2.0817 mL | 10.4084 mL | 20.8169 mL |
5 mM | 0.4163 mL | 2.0817 mL | 4.1634 mL |
10 mM | 0.2082 mL | 1.0408 mL | 2.0817 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >95.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet